TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
VCEL

Vericel Corp Ord

Healthcare · Biotechnology

39.70$ +1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow VCEL
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-88.2% -26.1% -36.6% -20.6% -0.5% -6.1% 14.2% 18.6% 10.8% 17.9% 24.5% 18.8%
2.6% 3.1% 3.5% 2.5% 1.6% 1.5% 1.9% 1.9% 2.4% 2.3% 2.3% 4.1%
2.9% 5.4% 4.6% 4.2% 7.9% 11.2% 11.1% 22.0% 22.6% 16.4% 15.4% 14.0%
-9.1% 6.0% 12.6% 6.3% 11.7% 11.2% 11.2% 22.0% 22.6% – – –
-8.8% -2.6% -17.0% -2.5% -4.4% -12.4% -5.1% -3.9% -6.8% -2.0% -0.2% -7.7%
2.9% 4.7% 2.6% 2.4% 2.9% 2.2% 2.1% 5.1% 4.6% 13.9% 27.0% 9.8%
-7.6% -4.7% -2.6% -2.4% -73.8% 9.0% -13.8% -2.2% -22.0% -1.6% -33.3% -15.9%
0.0% 0.0% 0.0% 0.0% – – – – – – – –
173.4% 0.0% 35.8% 19.5% 84.9% 4.5% 5.3% 7.2% 2.2% – – –
0.0% -0.1% 18.8% 9.6% -20.1% – – – -0.7% – – –
173.4% 0.0% 54.6% 29.1% 64.8% 4.5% 5.2% 5.9% 0.6% 1.8% 8.0% 2.6%
77.4% -30.8% 15.4% 6.1% -9.4% 7.4% 5.5% 22.2% -10.6% 18.1% -0.8% 5.4%
-91.1% -30.8% -39.2% -23.0% -3.4% -8.3% 12.0% 13.5% 6.1% 3.9% -2.4% 9.0%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?